Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q3 2024 · 10-Q
Revenue$282.74M$282.74M+2.6% vs Q3 2023 Net Income$53.05M$53.05M+2.1% vs Q3 2023 EPS Diluted$1.06$1.06+1.9% vs Q3 2023 Gross Profit$157,938,000+5.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$71,472,000+30.1% Free Cash Flowderived$69,476,000+30.7% Margins · derivedGross margin55.9%+1.3 pt vs Q3 2023
Operating margin30.7%−0.9 pt vs Q3 2023
Net margin18.8%−0.1 pt vs Q3 2023
ended Dec 31, 2023 · filed Feb 8, 2024 · 39 d after period end